A new scheme to bypass conflict of interest rules: the head of the US Covid-19 vaccine program was appointed with 10 million in stock in GlaxoSmithKline, one of the companies whose activity the program is involved with. (He got the stock as an employee.)

The cheater appointed him as a contractor rather than an employee and claims that this makes conflict of interest rules irrelevant — but that doesn't prevent conflicts of interest.